Please login to the form below

Not currently logged in
Email:
Password:

Chiltern promotes Richard Pilnik to chairman

He replaces Nick Thornton in the lead role

Chiltern Richard PilnikLondon and North Carolina-based clinical research organisation Chiltern has promoted Richard Pilnik to become its new chairman, succeeding Nick Thornton.

Pilnik became a member of the board of directors in 2015 bringing considerable industry experience across Asia, Europe, Latin America and the US to the firm.

Prior to joining Chiltern, Pilnik served as executive vice president at Quintiles and president of its Commercial Solutions division from 2009 until 2014.

He also brings leadership experience from Eli Lilly, which he joined in 1983 and subsequently held a number of senior positions including president for Europe, Middle East, Africa and CIS, and group vice president and chief marketing officer.

Jim Esinhart, chief executive officer of Chiltern, said: “On behalf of Chiltern's senior executive team and staff, as well as the investors and board of directors, I look forward to continuing to work with Rich in his new position as chairman.

“I would also like to thank Nick Thornton for his exceptional contribution to Chiltern over the past 10 years.”

9th June 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics